Description: The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.
Home Page: www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FBT
FBT Technical AnalysisExchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 89.02 | 0.00 | 89.02 |
| Stock non-US | 10.91 | 0.00 | 10.91 |
| Cash | 0.07 | 0.00 | 0.07 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.57 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 89.08 | 92.60 |
| Europe Developed | 10.92 | 4.28 |
| Japan | 0.00 | 0.54 |
| Australasia | 0.00 | 0.11 |
| Asia Emerging | 0.00 | 0.82 |
| United Kingdom | 0.00 | 1.65 |
| Africa/Middle East | 0.00 | 0.02 |